• 1.

    World Health Organization (WHO), 2013. Post-Kala-Azar Dermal Leishmaniasis: A Manual for Case Management and Control: Report of a Consultative Meeting, Kolkata, India, July 2–3, 2012. Geneva, Switzerland: WHO. Available at: http://apps.who.int/iris/bitstream/10665/78608/1/9789241505215_eng.pdf. Accessed October 14, 2014.

    • Search Google Scholar
    • Export Citation
  • 2.

    Zijlstra EE, Musa AM, Khalil EAG, El Hassan IM, 2003. Post kala-azar dermal leishmaniasis. Lancet Infect Dis 3: 8798.

  • 3.

    World Health Organization (WHO), 2015. Kala-Azar Elimination Program: Report of a WHO Consultation of Partners, Geneva, Switzerland, 10–11 February 2015. Geneva, Switzerland: WHO. Available at: http://apps.who.int/iris/bitstream/10665/185042/1/9789241509497_eng.pdf. Accessed February 4, 2016.

    • Search Google Scholar
    • Export Citation
  • 4.

    el-Hassan AM, Ghalib HW, Zylstra E, Eltoum IA, Ali MS, Ahmed HM, 1990. Post kala-azar dermal leishmaniasis in the absence of active visceral leishmaniasis. Lancet 336: 750.

    • Search Google Scholar
    • Export Citation
  • 5.

    Pal D, Naskar A, Ghosh MK, 2013. A case of miltefosine responsive pleomorphic post kala-azar dermal leishmaniasis. Braz J Infect Dis 17: 610612.

    • Search Google Scholar
    • Export Citation
  • 6.

    Islam S, Kenah E, Bhuiyan MA, Rahman KM, Goodhew B, Ghalib CM, Zahid MM, Ozaki M, Rahman MW, Haque R, Luby SP, Maguire JH, Martin D, Bern C, 2013. Clinical and immunological aspects of post-kala-azar dermal leishmaniasis in Bangladesh. Am J Trop Med Hyg 89: 345353.

    • Search Google Scholar
    • Export Citation
  • 7.

    Rahman KM, Islam S, Rahman MW, Kenah E, Ghalib CM, Zahid MM, Maguire J, Rahman M, Haque R, Luby SP, Bern C, 2010. Increasing incidence of post kala-azar dermal leishmaniasis in a population based study in Bangladesh. Clin Infect Dis 50: 7376.

    • Search Google Scholar
    • Export Citation
  • 8.

    Vallur AC, Duthie MS, Reinhart C, Tutterrow Y, Hamano S, Bhaskar KR, Coler RN, Mondal D, Reed SG, 2014. Biomarkers for intracellular pathogens: establishing tools as vaccine and therapeutic endpoints for visceral leishmaniasis. Clin Microbiol Infect 20: O374O383.

    • Search Google Scholar
    • Export Citation
  • 9.

    Chowdhury R, Mondal D, Chowdhury V, Faria S, Alvar J, Nabi SG, Boelaert M, Dash AP, 2014. How far are we from visceral leishmaniasis elimination in Bangladesh? An assessment of epidemiological surveillance data. PLoS Negl Trop Dis 8: e3020.

    • Search Google Scholar
    • Export Citation
  • 10.

    Shamsuzzaman AKM. National Guideline for Kala-azar Case Management (Draft). Kala-azar Elimination Program, Directorate General of Health Services, Ministry of Health and Family Welfare, Government of the People's Republic of Bangladesh.

    • Search Google Scholar
    • Export Citation
  • 11.

    Mondal D, Nasrin KN, Huda MM, Kabir M, Hossain MS, Kroeger A, Thomas T, Haque R, 2010. Enhanced case detection and improved diagnosis of PKDL in a kala-azar-endemic area of Bangladesh. PLoS Negl Trop Dis 4: e832.

    • Search Google Scholar
    • Export Citation
  • 12.

    Ramesh V, Kaushal H, Mishra AK, Singh R, Salotra P, 2015. Clinico-epidemiological analysis of post kala-azar dermal leishmaniasis (PKDL) cases in India over last two decades: a hospital based retrospective study. BMC Public Health 15: 1092.

    • Search Google Scholar
    • Export Citation
  • 13.

    Ramesh V, Katara GK, Verma S, Salotra P, 2011. Miltefosine as an effective choice in the treatment of post-kala-azar dermal leishmaniasis. Br J Dermatol 165: 411414.

    • Search Google Scholar
    • Export Citation
  • 14.

    Sundar S, Sinha P, Jha TK, Chakravarty J, Rai M, Kumar N, Pandey K, Narain MK, Verma N, Das VNR, Berman J, Arana B, 2013. Oral miltefosine for Indian post-kala-azar dermal leishmaniasis: a randomized trial. Trop Med Int Health 18: 96100.

    • Search Google Scholar
    • Export Citation
  • 15.

    Sundar S, Singh A, Chakravarty J, Rai M, 2015. Efficacy and safety of miltefosine in treatment of post kala-azar dermal leishmaniasis. ScientificWorldJournal 2015: 414378.

    • Search Google Scholar
    • Export Citation
 
 
 

 

 

 

 

 

 

Post-Kala-Azar Dermal Leishmaniasis Without Previous History of Visceral Leishmaniasis

View More View Less
  • 1 Centre for Clinical Epidemiology and Biostatistics (CCEB), School of Medicine and Public Health, Faculty of Health and Medicine, The University of Newcastle (UoN), New South Wales, Australia.
  • | 2 Nutrition and Clinical Services Division (NCSD), International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.
  • | 3 Department of Parasitology, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki, Japan.

Abstract

Post-kala-azar dermal leishmaniasis (PKDL) without previous visceral leishmaniasis (VL) is a rare dermatological manifestation of Leishmania infection. To date, most of the reported cases neither showed parasitological confirmation nor explained the outcome of treatment. Herein, we report three confirmed cases that were were successfully cured after miltefosine treatment.

Author Notes

* Address correspondence to Dinesh Mondal, Nutrition and Clinical Services Division (NCSD), International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), 68, Shaheed Tajuddin Ahmed Sarani, Mohakhali, Dhaka 1212, Bangladesh. E-mail: din63d@icddrb.org

Authors' addresses: Md Golam Hasnain, Faculty of Health and Medicine, University of Newcastle, New South Wales, Australia, and Nutrition and Clinical Service Division (NCSD), International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh, E-mail: mdgolam.hasnain@uon.edu.au. Mohammad Sohel Shomik, Prakash Ghosh, Mamun Or Rashid, Md Shakhawat Hossain, and Dinesh Mondal, Nutrition and Clinical Services Division (NCSD), International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh, E-mails: mshomik@icddrb.org, dreamix888@gmail.com, mamorrashid78@gmail.com, realengewe@yahoo.com, and din63d@icddrb.org. Shinjiro Hamano, Department of Parasitology, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan, E-mail: shinjiro@nagasaki-u.ac.jp.

Save